Rolta has denied the report from Glaucus Research which indicated fabrication of the reported capital expenditures in order to mask their materially overstated EBITDA. But Amit Tandon, MD of Institutional Investor Advisory Services is not convinced and says just a denial of charges by the company is not good enough.